New Findings Underscore Broad-Based Support for Market-Based Solutions to Hold
Big Pharma Accountable for Anti-Competitive Tactics That Keep Drug Prices High





 



ICYMI: I-MAK SURVEY FINDS FOUR IN FIVE AMERICANS SUPPORT PATENT REFORMS TO
LOWER PRESCRIPTION DRUG PRICES

New Findings Underscore Broad-Based Support for Market-Based Solutions to Hold
Big Pharma Accountable for Anti-Competitive Tactics That Keep Drug Prices High



In case you missed it, a recently released survey
<[link removed]> from The Initiative for
Medicines, Access, and Knowledge (I-MAK) finds across party lines, Americans
are deeply concerned with high prescription drug prices and overwhelmingly
support reforming the pharmaceutical patent system to boost competition and
lower prices.



According to I-MAK’s “Understanding Americans’ Top Concerns on Drug Pricing:
Corporate Greed” survey, conducted by Franklin & Marshall College’s Center for
Opinion Research, a 61 percent majority of American adults attribute high drug
prices to corporate greed and profit-seeking behavior from Big Pharma. A
massive 80 percent support changes to U.S. patent laws to address drug pricing.



The findings come as Big Pharma continues to game the U.S. patent system and
block competition from more affordable alternatives — enabling brand name drug
companies to extend monopolies over their biggest money-makers and price-gouge
American patients.



Other key findings from the survey include:

* Among those taking prescription medications, 31 percent reported skipping
at least one prescription in the past year due to cost. 15 percent of adults
who did not take prescriptions in the past year also reported skipping fills
because of cost.
* 58 percent of adults who take prescriptions report engaging in at least one
cost-saving behavior, including 31 percent who purchased an over-the-counter
substitute, 30 percent who delayed filling a prescription, and 27 percent who
took less medication to save money.
* 82 percent of Americans believe U.S. consumers pay more for the same drugs
than those in other developed countries.
* 84 percent of Americans say pharmaceutical companies make too much profit,
and 61 percent attribute high prices to corporate greed and profit-seeking
behavior.
* 90 percent of Americans support market-based reforms that make it easier
for generic drugs to come to market, and 90 percent back requiring public
disclosure of how drug prices are set.
The Trump administration recently announced
<[link removed]>
reforms to accelerate biosimilar approvals — an important step toward
fostering greater competition from more affordable alternatives to Big Pharma’s
high-priced brand name biologics and lowering prescription drug prices.



Congress should build on this positive momentum by advancing bipartisan,
market-based solutions, includingThe Affordable Prescriptions for Patients Act
<[link removed]>
,Q1/Q2 sameness reforms
<[link removed]>
and other solutions with proven support from both sides of the aisle, to crack
down on Big Pharma’s egregious anti-competitive practices.



Read the full report from I-MAK HERE
<[link removed]>.



Read more about Big Pharma’s patent abuse HERE
<[link removed]>
.



Learn more about bipartisan, market-based solutions to hold Big Pharma
accountableHERE <[link removed]>.



###

































Copyright © 2019 Campaign for Sustainable Rx Pricing
Our address is 1341 G St NW, #1100, Washington, DC xxxxxx


This email was sent to [email protected]. To unsubscribe please click
here.
<[link removed]>